Department of Molecular Biology, Aarhus University, 8000 Aarhus C, Denmark.
Epigenomics. 2010 Dec;2(6):823-40. doi: 10.2217/epi.10.51.
Deregulation of epigenetic and miRNA pathways are emerging as key events in carcinogenesis. miRNA genes can be epigenetically regulated and miRNAs can themselves repress key enzymes that drive epigenetic remodeling. Epigenetic and miRNA functions are thus tightly interconnected and crucial for maintaining correct local and global genomic architecture as well as gene-expression patterns, yet the underlying molecular mechanisms and their widespread effects remain poorly understood. Owing to the tissue specificity, versatility and relative stability of miRNAs, these small ncRNAs are considered especially promising in clinical applications, and their biogenesis and function is subject of active research. In this article, the current status of epigenetic miRNA regulation is summarized and future therapeutic prospects in the field are discussed with a focus on cancer.
表观遗传和 miRNA 通路的失调正逐渐成为癌症发生的关键事件。miRNA 基因可以被表观遗传调控,miRNAs 本身也可以抑制驱动表观遗传重塑的关键酶。因此,表观遗传和 miRNA 的功能紧密相关,对于维持正确的局部和全局基因组结构以及基因表达模式至关重要,但潜在的分子机制及其广泛的影响仍知之甚少。由于 miRNAs 的组织特异性、多功能性和相对稳定性,这些小 ncRNAs 在临床应用中被认为特别有前途,其生物发生和功能是当前研究的热点。本文总结了表观遗传 miRNA 调控的现状,并讨论了该领域的未来治疗前景,重点关注癌症。